We can't find the internet
Attempting to reconnect
18540.1 IP-LS
18540.1 IP-LS
Zusammenfassung
Engineered arrestins as novel biosensors for drug-induced GPCR phosphorylation
Weitere Texte
Abstract
Promising drug candidates entering pre- and clinical trials account for more than 50% of the total Pharma R&D|spending and have a failure rate of 95%. About half of them target GPCRs, an important superfamily of|membrane receptors. For better and earlier assessment of quality, safety, and effectiveness of drug|candidates, we will develop cellular screening systems on a unique arrestin-engineering platform to enable|high-throughput dissection of drug-induced GPCR signaling.
Beteiligte
Maria Waldhoer
Wirtschaftspartner
waldhoer@interaxbiotech.com
InterAx Biotech AG Maria Waldhoer PARK innovAARE 5234 Villigen AG CH
Gebhard Schertler
Kontaktperson
gebhard.schertler@psi.ch
PSI Paul Scherrer Institut Gebhard Schertler 5232 Villigen AG CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2016-06-30
- Enddatum
- 2019-11-30
- Bewilligte Gesamtkosten
- CHF 493680.00
- Sektion
- 60 Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T490 Biotechnology 100.0%